The company will take all necessary steps to work with USFDA towards earliest remediation of the above facility
Higher revenues backed by huge demand and expanding network contributed to the growth in bottom line
The drugmaker's net profit slipped 26 per cent on-year to Rs 143.8 crore
Rusan’s API facility in Ankleshwar is GMP approved by other stringent international agencies as well
The facility is a part of Lupin Manufacturing Solutions
The Unit has been issued GMP Certification from ANVISA-Brazil
This product will be manufactured at Lupin’s Pithampur facility in India
States urged to maintain a state of constant vigil through screening of pregnant women for Zika virus infection and monitoring the growth of foetus of expecting mothers who tested positive for Zika
Partners with Yifan Pharmaceutical to launch Synovian injection for osteoarthritis in China
Laurus Labs receives EIR from USFDA for API facilities
Subscribe To Our Newsletter & Stay Updated
